aspirin has been researched along with Carcinoma, Basal Cell, Pigmented in 11 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "BCC incidence was evaluated in a randomized, double-blind, placebo-controlled clinical trial of aspirin (81 mg daily or 325 mg daily for ~3 years) and/or folic acid (1 mg daily for ~6 years) for the prevention of colorectal adenomas among 1121 participants with a previous adenoma." | 9.27 | Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas. ( Baron, JA; Barry, EL; Bresalier, RS; Gangar, P; Karagas, MR; McKeown-Eyssen, G; Passarelli, MN; Rees, JR; Zhang, D, 2018) |
| "BCC incidence was evaluated in a randomized, double-blind, placebo-controlled clinical trial of aspirin (81 mg daily or 325 mg daily for ~3 years) and/or folic acid (1 mg daily for ~6 years) for the prevention of colorectal adenomas among 1121 participants with a previous adenoma." | 5.27 | Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas. ( Baron, JA; Barry, EL; Bresalier, RS; Gangar, P; Karagas, MR; McKeown-Eyssen, G; Passarelli, MN; Rees, JR; Zhang, D, 2018) |
| "Neither aspirin nor non-aspirin NSAID use was associated with a lower risk of melanoma, SCC, or BCC, even for women with high quantity, frequency, or duration of use." | 3.78 | Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study. ( Alberts, DS; Feskanich, D; Han, J; Jeter, JM; Martinez, ME; Qureshi, AA, 2012) |
| " However, severe and numerous adverse events are associated with vismodegib use." | 2.52 | Cholestatic hepatic injury associated with vismodegib, aspirin, and naproxen use: a case study and review of vismodegib safety. ( Ash, MM; Jolly, PS, 2015) |
| "Aspirin use was associated with reduced risk of SCC (HR 0·77, 95% confidence interval 0·64-0·93) only among infrequent (less than weekly) users and was not associated with BCC." | 1.51 | Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia. ( Dusingize, JC; Green, AC; Neale, RE; Olsen, CM; Pandeya, N; Thompson, BS; Whiteman, DC, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Passarelli, MN | 1 |
| Barry, EL | 1 |
| Zhang, D | 1 |
| Gangar, P | 1 |
| Rees, JR | 1 |
| Bresalier, RS | 1 |
| McKeown-Eyssen, G | 1 |
| Karagas, MR | 2 |
| Baron, JA | 1 |
| Pandeya, N | 2 |
| Olsen, CM | 2 |
| Thompson, BS | 1 |
| Dusingize, JC | 1 |
| Neale, RE | 1 |
| Green, AC | 2 |
| Whiteman, DC | 1 |
| Ash, MM | 1 |
| Jolly, PS | 1 |
| Reinau, D | 1 |
| Surber, C | 1 |
| Jick, SS | 1 |
| Meier, CR | 1 |
| Muranushi, C | 1 |
| Clouser, MC | 1 |
| Roe, DJ | 1 |
| Foote, JA | 1 |
| Harris, RB | 1 |
| Torti, DC | 1 |
| Christensen, BC | 1 |
| Storm, CA | 1 |
| Fortuny, J | 1 |
| Perry, AE | 1 |
| Zens, MS | 1 |
| Stukel, T | 1 |
| Spencer, SK | 1 |
| Nelson, HH | 1 |
| Jeter, JM | 1 |
| Han, J | 1 |
| Martinez, ME | 1 |
| Alberts, DS | 1 |
| Qureshi, AA | 1 |
| Feskanich, D | 1 |
| Alam, M | 1 |
| Goldberg, LH | 2 |
| Kimyai-Asadi, A | 1 |
| Jih, MH | 1 |
| FitzGerald, K | 1 |
| Stephens, N | 1 |
| Newman, L | 1 |
| Venn, A | 1 |
3 reviews available for aspirin and Carcinoma, Basal Cell, Pigmented
| Article | Year |
|---|---|
Cholestatic hepatic injury associated with vismodegib, aspirin, and naproxen use: a case study and review of vismodegib safety.
Topics: Aged; Anilides; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Carcinoma, | 2015 |
Can oral nonsteroidal antiinflammatory drugs play a role in the prevention of basal cell carcinoma? A systematic review and metaanalysis.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, Basal Cell; Femal | 2016 |
Perioperative primary stroke: is aspirin cessation to blame?
Topics: Aged; Aspirin; Carcinoma, Basal Cell; Diagnosis, Differential; Drug Administration Schedule; Humans; | 2004 |
2 trials available for aspirin and Carcinoma, Basal Cell, Pigmented
| Article | Year |
|---|---|
Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas.
Topics: Adenoma; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, Basal Cell; Colorectal N | 2018 |
Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Arizona; Aspirin; Carcinoma, Basal | 2009 |
6 other studies available for aspirin and Carcinoma, Basal Cell, Pigmented
| Article | Year |
|---|---|
Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, Basal Cell; Carcinoma, Squ | 2019 |
Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, Basal Cell; Ca | 2015 |
Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: a population-based case-control study.
Topics: Acetaminophen; Adult; Age Distribution; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; A | 2011 |
Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, Basal Cell; Carcinoma, S | 2012 |
Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy.
Topics: Aged; Anticoagulants; Aspirin; Carcinoma, Basal Cell; Clopidogrel; Drug Administration Schedule; Fem | 2002 |
Inaccuracies in self-reported histories of non-melanoma skin cancer.
Topics: Aspirin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; False Negative Reactions; False Positive R | 2007 |